These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 11931779

  • 1. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
    Mather R, Karenchak LM, Romanowski EG, Kowalski RP.
    Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
    [Abstract] [Full Text] [Related]

  • 2. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 4. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV.
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [Abstract] [Full Text] [Related]

  • 5. Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
    Reddy AK, Garg P, Alam MR, Gopinathan U, Sharma S, Krishnaiah S.
    Eye (Lond); 2010 Jan; 24(1):170-4. PubMed ID: 19229279
    [Abstract] [Full Text] [Related]

  • 6. Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection.
    Oliveira AD, Höfling-Lima AL, Belfort R, Gayoso Mde F, Francisco W.
    Arq Bras Oftalmol; 2007 Jan; 70(2):286-9. PubMed ID: 17589701
    [Abstract] [Full Text] [Related]

  • 7. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.
    Indian J Ophthalmol; 2007 Jan; 55(1):15-9. PubMed ID: 17189881
    [Abstract] [Full Text] [Related]

  • 8. [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico].
    Calva-Mercado JJ, Castillo G, López-Vidal Y.
    Gac Med Mex; 2005 Jan; 141(4):253-8. PubMed ID: 16164118
    [Abstract] [Full Text] [Related]

  • 9. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R, Ramesh S, Bharathi MJ, Amuthan M, Viswanathan S.
    Indian J Pathol Microbiol; 2010 Jan; 53(2):276-80. PubMed ID: 20551532
    [Abstract] [Full Text] [Related]

  • 10. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
    Deramo VA, Lai JC, Fastenberg DM, Udell IJ.
    Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
    [Abstract] [Full Text] [Related]

  • 11. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA, Galvis V, Tello A, Villareal D, Rey JJ.
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [Abstract] [Full Text] [Related]

  • 12. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, Díaz PL, Castañeda E, Arias CA.
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
    Blondeau JM, Laskowski R, Bjarnason J, Stewart C.
    Int J Antimicrob Agents; 2000 Feb; 14(1):45-50. PubMed ID: 10717500
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients.
    Chung JL, Seo KY, Yong DE, Mah FS, Kim TI, Kim EK, Kim JK.
    Ophthalmology; 2009 Jun; 116(6):1067-74. PubMed ID: 19395038
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
    Madhusudhan KT, Counts C, Lody C, Carter O, Dodson S, Ojha N.
    Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
    [Abstract] [Full Text] [Related]

  • 16. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
    Pong A, Thomson KS, Moland ES, Chartrand SA, Sanders CC.
    J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
    [Abstract] [Full Text] [Related]

  • 17. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK, Gordon YJ.
    Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
    [Abstract] [Full Text] [Related]

  • 18. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC, Novosad BD, Ramadan RT, Wiskur B, Moyer AL.
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
    Bauernfeind A.
    J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of fluoroquinolones against common respiratory pathogens.
    Aydemir S, Tunger A, Cilli F.
    West Indian Med J; 2006 Jan; 55(1):9-12. PubMed ID: 16755812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.